Severe Rsv Infection

Routine childhood immunizations have prevented 1.1 million deaths in the United States since the CDC’s Vaccines for Children program launched in 1994, according to researchers.

Palivizumab was consistently found to be cost-effective as prophylaxis for respiratory syncytial virus disease among neonates on four continents, according to a study presented at the Pediatric Academic Societies Meeting.